title: Tigecycline disk diffusion breakpoints of Acinetobacter spp.: a clinical point of view.
authors.forename: Daniel
authors.initials: D
authors.lastname: Curcio
authors.forename: Francisco
authors.initials: F
authors.lastname: Fernández
authors.forename: Ronald N
authors.initials: RN
authors.lastname: Jones
authors.forename: Mary Jane
authors.initials: MJ
authors.lastname: Ferraro
authors.forename: L Barth
authors.initials: LB
authors.lastname: Reller
authors.forename: Paul C
authors.initials: PC
authors.lastname: Schreckenberger
authors.forename: Helio S
authors.initials: HS
authors.lastname: Sader
mesh_terms: D000150:Acinetobacter / Q000145:classification / Q000187:drug effects*; D000151:Acinetobacter Infections / Q000382:microbiology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D024881:Drug Resistance, Bacterial; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000379:methods / Q000592:standards*; D008911:Minocycline / Q000031:analogs & derivatives* / Q000494:pharmacology; D000078304:Tigecycline
chemical_list: D000900:Anti-Bacterial Agents; D000078304:Tigecycline; D008911:Minocycline